XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Revenues $ 26,799 $ 23,632 $ 80,126 $ 65,961
Cost of revenues 23,227 19,676 69,925 51,444
Gross margin 3,572 3,956 10,201 14,517
Operating expenses:        
Research and development 2,657 3,029 8,368 8,248
Selling, general and administrative 6,777 7,085 20,615 18,609
Amortization of acquisition-related intangibles 628 360 1,840 601
Change in fair value of contingent consideration (2,110) 2,740 (4,440) 2,740
Total operating expenses 7,952 13,214 26,383 30,198
Operating loss (4,380) (9,258) (16,182) (15,681)
Interest income, net 12 53 68 373
Other income (expense), net 45 (274) 7 (920)
Loss before income tax expense (benefit) (4,323) (9,479) (16,107) (16,228)
Income tax expense (benefit) 1 (1,546) (1,946) (1,166)
Net loss $ (4,324) $ (7,933) $ (14,161) $ (15,062)
Net loss per common share        
Basic (in dollars per share) $ (0.16) $ (0.31) $ (0.52) $ (0.65)
Diluted (in dollars per share) $ (0.16) $ (0.31) $ (0.52) $ (0.65)
Weighted average number of common shares outstanding        
Basic (in shares) 27,352 25,470 27,145 23,011
Diluted (in shares) 27,352 25,470 27,145 23,011